Personalized medicine aims to tailor treatments to individual patients. Until now, this has been done using a small number of parameters to predict the course of a disease. However, these few ...

Thinkers and doers across the industry agree that AI is a double-edged sword, reducing some complexity while adding more.

One key driver is the growing complexity of trial designs. The global artificial intelligence (AI)-based clinical trial ...

Rats perceive the world with a complexity that modern artificial neural networks struggle to match. This is the finding of a recent study published in the journal Patterns by the Visual Neuroscience ...

Personalized medicine aims to tailor treatments to individual patients. Until now, this has been done using a small number of ...

Amid the industry fervor over DeepSeek, the Seattle-based Allen Institute for AI (Ai2) released a significantly larger ...

Our tendency for cognitive simplification is dangerous, especially in an AI-infused landscape. Explore four practical steps ...

Researchers from Stanford and leading institutions introduced the Artificial Intelligence Pricing Model (AIPM), integrating ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.